z-logo
open-access-imgOpen Access
In Vitro and In Vivo Evaluation of Oxatomide β-Cyclodextrin Inclusion Complex
Author(s) -
Fahima Hashem,
Mohamed M. Mostafa,
Mahmoud A. Shaker,
Mohamed Nasr
Publication year - 2012
Publication title -
journal of pharmaceutics
Language(s) - English
Resource type - Journals
eISSN - 2090-7818
pISSN - 2090-9918
DOI - 10.1155/2013/629593
Subject(s) - bioavailability , cyclodextrin , chemistry , in vivo , pharmacology , dissolution , chromatography , organic chemistry , medicine , microbiology and biotechnology , biology
The objective of this study was to evaluate the influence of oxatomide β -cyclodextrin inclusion complex on the physicochemical properties and bioavailability of the drug. Oxatomide β -cyclodextrin solid complex was prepared with equimolar ratio of both oxatomide and β -cyclodextrin in presence or absence of water soluble polymers using different techniques. The coevaporated complex prepared in presence of PVP-K15 showed a prompt drug release and significantly increased % dissolution efficiency ( P < 0.05) compared to the pure oxatomide. Moreover, the results of bioavailability evaluation of this complex in rabbits compared to commercial drug product indicated a 73.15% increase in the oral bioavailability of oxatomide. In conclusion, inclusion complex of oxatomide with β -cyclodextrin prepared by coevaporation in presence of PVP-K15 not only results in an enhancement of the oxatomide dissolution rate but also improves the bioavailability of oxatomide.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom